OMB control number

Qualitative Feedback on Food and Drug Administration Service Delivery

OMB 0910-0697 · HHS/FDA.

OMB 0910-0697

The information collected from our customers and stakeholders will help ensure that users have an effective, efficient, and satisfying experience with FDA's programs. This feedback will provide insights into customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve delivery of products or services. These collections will allow for ongoing, collaborative and actionable communications between FDA and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program management.

The latest form for Qualitative Feedback on Food and Drug Administration Service Delivery expires 2027-01-31 and is listed under ICR 202311-0910-013.

Latest Forms, Documents, and Supporting Material

Latest forms, documents, and information collections
DocumentType
0697 summaries FINAL.docx Supplementary Document
0697 OMB Memo Template FINAL.docx Supplementary Document
0697 83-C July 2022.docx Justification for No Material/Nonsubstantive Change
0697 Supporting Statement Part B 2020.docxSupporting Statement B
0697 SSA FINAL.docxSupporting Statement A
(OC) Assessments of Patient and Patient Advocate Experience with the FDA For Patients Website and FDA Patient Listening Session program Other-Interview guide

All Historical Document Collections

OMB Details

(OC) Assessments of Patient and Patient Advocate Experience with the FDA For Patients Website and FDA Patient Listening Session program

Federal Enterprise Architecture: Health - Consumer Health and Safety